225 related articles for article (PubMed ID: 26028029)
1. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer: PTEN loss and PSGR overexpression promote cancer progression.
Stone L
Nat Rev Urol; 2015 Jul; 12(7):364. PubMed ID: 26077992
[No Abstract] [Full Text] [Related]
3. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
4. Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion.
Rodriguez M; Siwko S; Liu M
Curr Mol Med; 2016; 16(6):526-32. PubMed ID: 27280498
[TBL] [Abstract][Full Text] [Related]
5. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.
Xu LL; Stackhouse BG; Florence K; Zhang W; Shanmugam N; Sesterhenn IA; Zou Z; Srikantan V; Augustus M; Roschke V; Carter K; McLeod DG; Moul JW; Soppett D; Srivastava S
Cancer Res; 2000 Dec; 60(23):6568-72. PubMed ID: 11118034
[TBL] [Abstract][Full Text] [Related]
6. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
[TBL] [Abstract][Full Text] [Related]
7. Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation.
Xie H; Liu T; Chen J; Yang Z; Xu S; Fan Y; Zeng J; Chen Y; Ma Z; Gao Y; He D; Li L
Cancer Lett; 2019 Jul; 453():193-205. PubMed ID: 30928381
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression profile of PSGR in prostate cancer.
Xu LL; Sun C; Petrovics G; Makarem M; Furusato B; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2006; 9(1):56-61. PubMed ID: 16231015
[TBL] [Abstract][Full Text] [Related]
9. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
[TBL] [Abstract][Full Text] [Related]
10. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.
Weng J; Wang J; Cai Y; Stafford LJ; Mitchell D; Ittmann M; Liu M
Int J Cancer; 2005 Feb; 113(5):811-8. PubMed ID: 15499628
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.
Moselhy J; Suman S; Alghamdi M; Chandarasekharan B; Das TP; Houda A; Ankem M; Damodaran C
Neoplasia; 2017 Jun; 19(6):451-459. PubMed ID: 28494348
[TBL] [Abstract][Full Text] [Related]
13. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
14. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
[TBL] [Abstract][Full Text] [Related]
15. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
[TBL] [Abstract][Full Text] [Related]
16. PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB.
Rodriguez M; Luo W; Weng J; Zeng L; Yi Z; Siwko S; Liu M
Oncogenesis; 2014 Aug; 3(8):e114. PubMed ID: 25111863
[TBL] [Abstract][Full Text] [Related]
17. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
[TBL] [Abstract][Full Text] [Related]
18. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
[TBL] [Abstract][Full Text] [Related]
19. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
[TBL] [Abstract][Full Text] [Related]
20. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Olson A; Le V; Aldahl J; Yu EJ; Hooker E; He Y; Lee DH; Kim WK; Cardiff RD; Geradts J; Sun Z
PLoS Genet; 2019 Oct; 15(10):e1008451. PubMed ID: 31658259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
